Daily	O
Use	O
of	O
a	O
Facial	O
Broad	O
Spectrum	O
Sunscreen	O
Over	O
One	O
-	O
Year	O
Significantly	O
Improves	O
Clinical	B:C4084924
Evaluation	I:C4084924
of	O
Photoaging	O
.	O

Daily	O
Use	O
of	O
a	O
Facial	O
Broad	O
Spectrum	O
Sunscreen	O
Over	O
One	O
-	O
Year	O
Significantly	O
Improves	O
Clinical	O
Evaluation	I:C4084924
of	O
Photoaging	B:C0263415
.	O

Sunscreens	O
are	O
known	O
to	O
protect	O
from	O
sun	O
damage	O
;	O
however	O
,	O
their	O
effects	O
on	O
the	O
reversal	O
of	O
photodamage	B:C1281591
have	O
been	O
minimally	O
investigated	O
.	O

The	O
aim	O
of	O
the	O
prospective	B:C0033522
study	I:C0033522
was	O
to	O
evaluate	O
the	O
efficacy	O
of	O
a	O
facial	O
sun	O
protection	I:C1254351
factor	I:C1254351
(	I:C1254351
SPF	I:C1254351
)	I:C1254351
30	I:C1254351
formulation	I:C1254351
for	O
the	O
improvement	O
of	O
photodamage	O
during	O
a	O
1	O
-	O
year	O
use	O
.	O

The	O
aim	O
of	O
the	O
prospective	O
study	I:C0033522
was	O
to	O
evaluate	O
the	O
efficacy	O
of	O
a	O
facial	O
sun	B:C1254351
protection	I:C1254351
factor	I:C1254351
(	I:C1254351
SPF	I:C1254351
)	I:C1254351
30	I:C1254351
formulation	I:C1254351
for	O
the	O
improvement	O
of	O
photodamage	O
during	O
a	O
1	O
-	O
year	O
use	O
.	O

Thirty	O
-	O
two	O
subjects	B:C0080105
applied	O
a	O
broad	O
spectrum	O
photostable	O
sunscreen	O
(	O
SPF	O
30	O
)	O
for	O
52	O
weeks	O
to	O
the	O
entire	O
face	I:C1281591
.	O

Thirty	O
-	O
two	O
subjects	O
applied	O
a	O
broad	O
spectrum	O
photostable	O
sunscreen	O
(	O
SPF	O
30	O
)	O
for	O
52	O
weeks	O
to	O
the	O
entire	B:C1281591
face	I:C1281591
.	O

Assessments	B:C1261322
were	O
conducted	O
through	O
dermatologist	O
evaluations	O
and	O
subjects	O
'	O
self	O
-	I:C0036591
assessment	I:C0036591
at	O
baseline	O
and	O
then	O
at	O
Weeks	O
12	O
,	O
24	O
,	O
36	O
,	O
and	O
52	O
.	O

Assessments	O
were	O
conducted	O
through	O
dermatologist	B:C0259831
evaluations	O
and	O
subjects	O
'	O
self	O
-	I:C0036591
assessment	I:C0036591
at	O
baseline	O
and	O
then	O
at	O
Weeks	O
12	O
,	O
24	O
,	O
36	O
,	O
and	O
52	O
.	O

Assessments	O
were	O
conducted	O
through	O
dermatologist	O
evaluations	B:C0220825
and	O
subjects	O
'	O
self	O
-	I:C0036591
assessment	I:C0036591
at	O
baseline	O
and	O
then	O
at	O
Weeks	O
12	O
,	O
24	O
,	O
36	O
,	O
and	O
52	O
.	O

Assessments	O
were	O
conducted	O
through	O
dermatologist	O
evaluations	O
and	O
subjects	B:C0080105
'	O
self	O
-	I:C0036591
assessment	I:C0036591
at	O
baseline	O
and	O
then	O
at	O
Weeks	O
12	O
,	O
24	O
,	O
36	O
,	O
and	O
52	O
.	O

Assessments	O
were	O
conducted	O
through	O
dermatologist	O
evaluations	O
and	O
subjects	O
'	O
self	B:C0036591
-	I:C0036591
assessment	I:C0036591
at	O
baseline	O
and	O
then	O
at	O
Weeks	O
12	O
,	O
24	O
,	O
36	O
,	O
and	O
52	O
.	O

Clinical	B:C4084924
evaluations	I:C4084924
showed	O
that	O
all	O
photoaging	O
parameters	O
improved	O
significantly	O
from	O
baseline	O
as	O
early	O
as	O
Week	O
12	O
and	O
the	O
amelioration	O
continued	O
until	O
Week	O
52	O
.	O

Clinical	O
evaluations	I:C4084924
showed	O
that	O
all	O
photoaging	B:C0263415
parameters	O
improved	O
significantly	O
from	O
baseline	O
as	O
early	O
as	O
Week	O
12	O
and	O
the	O
amelioration	O
continued	O
until	O
Week	O
52	O
.	O

Clinical	O
evaluations	I:C4084924
showed	O
that	O
all	O
photoaging	O
parameters	B:C0449381
improved	O
significantly	O
from	O
baseline	O
as	O
early	O
as	O
Week	O
12	O
and	O
the	O
amelioration	O
continued	O
until	O
Week	O
52	O
.	O

Skin	B:C0423752
texture	I:C0423752
,	O
clarity	O
,	O
and	O
mottled	O
and	O
discrete	O
pigmentation	O
were	O
the	O
most	O
improved	O
parameters	O
by	O
the	O
end	O
of	O
the	O
study	O
(	O
40	O
%	O
to	O
52	O
%	O
improvement	O
from	O
baseline	O
)	O
,	O
with	O
100	O
%	O
of	O
subjects	O
showing	O
improvement	O
in	O
skin	O
clarity	I:C0243095
and	O
texture	O
.	O

Skin	O
texture	I:C0423752
,	O
clarity	B:C0243095
,	O
and	O
mottled	O
and	O
discrete	O
pigmentation	O
were	O
the	O
most	O
improved	O
parameters	O
by	O
the	O
end	O
of	O
the	O
study	O
(	O
40	O
%	O
to	O
52	O
%	O
improvement	O
from	O
baseline	O
)	O
,	O
with	O
100	O
%	O
of	O
subjects	O
showing	O
improvement	O
in	O
skin	O
clarity	I:C0243095
and	O
texture	O
.	O

Skin	O
texture	I:C0423752
,	O
clarity	O
,	O
and	O
mottled	B:C0302133
and	O
discrete	O
pigmentation	O
were	O
the	O
most	O
improved	O
parameters	O
by	O
the	O
end	O
of	O
the	O
study	O
(	O
40	O
%	O
to	O
52	O
%	O
improvement	O
from	O
baseline	O
)	O
,	O
with	O
100	O
%	O
of	O
subjects	O
showing	O
improvement	O
in	O
skin	O
clarity	I:C0243095
and	O
texture	O
.	O

Skin	O
texture	I:C0423752
,	O
clarity	O
,	O
and	O
mottled	O
and	O
discrete	O
pigmentation	O
were	O
the	O
most	O
improved	O
parameters	B:C0449381
by	O
the	O
end	O
of	O
the	O
study	O
(	O
40	O
%	O
to	O
52	O
%	O
improvement	O
from	O
baseline	O
)	O
,	O
with	O
100	O
%	O
of	O
subjects	O
showing	O
improvement	O
in	O
skin	O
clarity	I:C0243095
and	O
texture	O
.	O

Skin	O
texture	I:C0423752
,	O
clarity	O
,	O
and	O
mottled	O
and	O
discrete	O
pigmentation	O
were	O
the	O
most	O
improved	O
parameters	O
by	O
the	O
end	O
of	O
the	O
study	B:C2603343
(	O
40	O
%	O
to	O
52	O
%	O
improvement	O
from	O
baseline	O
)	O
,	O
with	O
100	O
%	O
of	O
subjects	O
showing	O
improvement	O
in	O
skin	O
clarity	I:C0243095
and	O
texture	O
.	O

Skin	O
texture	I:C0423752
,	O
clarity	O
,	O
and	O
mottled	O
and	O
discrete	O
pigmentation	O
were	O
the	O
most	O
improved	O
parameters	O
by	O
the	O
end	O
of	O
the	O
study	O
(	O
40	O
%	O
to	O
52	O
%	O
improvement	O
from	O
baseline	O
)	O
,	O
with	O
100	O
%	O
of	O
subjects	B:C0080105
showing	O
improvement	O
in	O
skin	O
clarity	I:C0243095
and	O
texture	O
.	O

Skin	O
texture	I:C0423752
,	O
clarity	O
,	O
and	O
mottled	O
and	O
discrete	O
pigmentation	O
were	O
the	O
most	O
improved	O
parameters	O
by	O
the	O
end	O
of	O
the	O
study	O
(	O
40	O
%	O
to	O
52	O
%	O
improvement	O
from	O
baseline	O
)	O
,	O
with	O
100	O
%	O
of	O
subjects	O
showing	O
improvement	O
in	O
skin	B:C0243095
clarity	I:C0243095
and	O
texture	O
.	O

Skin	O
texture	I:C0423752
,	O
clarity	O
,	O
and	O
mottled	O
and	O
discrete	O
pigmentation	O
were	O
the	O
most	O
improved	O
parameters	O
by	O
the	O
end	O
of	O
the	O
study	O
(	O
40	O
%	O
to	O
52	O
%	O
improvement	O
from	O
baseline	O
)	O
,	O
with	O
100	O
%	O
of	O
subjects	O
showing	O
improvement	O
in	O
skin	O
clarity	I:C0243095
and	O
texture	B:C0423752
.	O

The	O
daily	O
use	O
of	O
a	O
facial	O
broad	O
-	O
spectrum	O
photostable	O
sunscreen	O
may	O
visibly	O
reverse	O
the	O
signs	O
of	O
existing	O
photodamage	B:C1281591
,	O
in	O
addition	O
to	O
preventing	O
additional	O
sun	O
damage	O
.	O

